|
Name |
(Z)-13-Octadecenal
|
| Molecular Formula | C18H34O | |
| IUPAC Name* |
(Z)-octadec-13-enal
|
|
| SMILES |
CCCC/C=C\CCCCCCCCCCCC=O
|
|
| InChI |
InChI=1S/C18H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h5-6,18H,2-4,7-17H2,1H3/b6-5-
|
|
| InChIKey |
QIRGIHPYVVKWTO-WAYWQWQTSA-N
|
|
| Synonyms |
(Z)-13-Octadecenal; 58594-45-9; (Z)-octadec-13-enal; 13-Octadecenal, (13Z)-; 13-Octadecenal, (Z)-; 13Z-Octadecenal; FJA253248W; Z-13-Octadecanal; cis-13-Octadecenal; 13Z-Octadecanal; (13Z)-13-Octadecenal; UNII-FJA253248W; Z-13-Octadecenal; EINECS 261-349-4; (13Z)-octadec-13-enal; SCHEMBL811956; (13Z)-13-Octadecenal #; DTXSID2035774; OCTADECENAL, (Z)-13-; LMFA06000237; ZINC33840740; Q27278021
|
|
| CAS | 58594-45-9 | |
| PubChem CID | 5364497 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 266.5 | ALogp: | 7.2 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
| Heavy Atoms: | 19 | QED Weighted: | 0.195 |
| Caco-2 Permeability: | -4.868 | MDCK Permeability: | 0.00002110 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.018 | 20% Bioavailability (F20%): | 0.997 |
| 30% Bioavailability (F30%): | 0.999 |
| Blood-Brain-Barrier Penetration (BBB): | 0.67 | Plasma Protein Binding (PPB): | 93.84% |
| Volume Distribution (VD): | 4.084 | Fu: | 1.63% |
| CYP1A2-inhibitor: | 0.218 | CYP1A2-substrate: | 0.207 |
| CYP2C19-inhibitor: | 0.348 | CYP2C19-substrate: | 0.067 |
| CYP2C9-inhibitor: | 0.165 | CYP2C9-substrate: | 0.948 |
| CYP2D6-inhibitor: | 0.549 | CYP2D6-substrate: | 0.65 |
| CYP3A4-inhibitor: | 0.402 | CYP3A4-substrate: | 0.059 |
| Clearance (CL): | 3.585 | Half-life (T1/2): | 0.621 |
| hERG Blockers: | 0.477 | Human Hepatotoxicity (H-HT): | 0.025 |
| Drug-inuced Liver Injury (DILI): | 0.036 | AMES Toxicity: | 0.13 |
| Rat Oral Acute Toxicity: | 0.018 | Maximum Recommended Daily Dose: | 0.045 |
| Skin Sensitization: | 0.978 | Carcinogencity: | 0.186 |
| Eye Corrosion: | 0.989 | Eye Irritation: | 0.987 |
| Respiratory Toxicity: | 0.949 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001694 | ![]() |
0.825 | D0O1PH | ![]() |
0.635 | ||
| ENC001691 | ![]() |
0.783 | D0O1TC | ![]() |
0.475 | ||
| ENC001775 | ![]() |
0.750 | D0Z5SM | ![]() |
0.473 | ||
| ENC001681 | ![]() |
0.746 | D05ATI | ![]() |
0.457 | ||
| ENC001666 | ![]() |
0.733 | D07ILQ | ![]() |
0.456 | ||
| ENC001665 | ![]() |
0.726 | D0OR6A | ![]() |
0.417 | ||
| ENC001591 | ![]() |
0.723 | D00AOJ | ![]() |
0.402 | ||
| ENC001592 | ![]() |
0.723 | D0UE9X | ![]() |
0.400 | ||
| ENC001699 | ![]() |
0.723 | D00FGR | ![]() |
0.383 | ||
| ENC001555 | ![]() |
0.723 | D0P1RL | ![]() |
0.340 | ||